Traditional Chinese medicine composition for treating precancerous lesions of gastric cancer as well as preparation method and application of traditional Chinese medicine composition

Through the method of removing turbidity and detoxification combined with the effects of traditional Chinese medicine composition to reduce swelling, clear heat, detoxify, strengthen the spleen and replenish qi, the problem that the existing technology cannot effectively treat precancerous gastric lesions, and achieve significant clinical efficacy and serum markers reduction, providing new ideas for the treatment and prevention of precancerous gastric lesions.

CN118924849APending Publication Date: 2024-11-12TANGSHAN PEOPLES HOSPITAL
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411128816.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art cannot effectively treat gastric precancerous lesions, there is a lack of corresponding disease names in ancient Chinese medicine books, and the existing treatment methods for Chinese medicine compositions cannot achieve effective treatment for gastric precancerous lesions.

Method used

By using the method of removing turbidity and detoxification, Chinese herbal compositions such as Agastache, Perilla, Yinchen, Coptis chinensis, Citrus aurantium, Atractylodes, White Flower Snake, Half-Biancao, Snakeberry, Vines, Pear Root, Dongling Grass and Red Qu , using its effects such as reducing swelling, clearing heat and detoxifying, strengthening the spleen and replenishing qi, forming a traditional Chinese medicine composition, which can eliminate dampness, detoxify, promote dampness and promote blood circulation.

Benefits of technology

Significantly reduce the clinical syndrome points of precancerous gastric lesions, improve gastric mucosal congestion, edema, erosion, red and white, naked blood vessels, bile reflux and granular hyperplasia, reduce the level of serum tumor markers, and the total effective efficiency reaches more than 93%. , better than Western medicine treatment effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004997404250000061
    Figure BDA0004997404250000061
  • Figure BDA0004997404250000071
    Figure BDA0004997404250000071
  • Figure BDA0004997404250000072
    Figure BDA0004997404250000072
Patent Text Reader

Abstract

The invention provides a traditional Chinese medicine composition for treating gastric precancerous lesions as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by mass: 10 to 15 parts of agastache rugosus, 9 to 12 parts of herba eupatorii, 12 to 15 parts of herba artemisiae scopariae, 10 to 12 parts of rhizoma coptidis, 10 to 12 parts of fructus aurantii immaturus, 9 to 12 parts of rhizoma atractylodis macrocephalae, 12 to 20 parts of herba hedyotidis diffusae, 12 to 20 parts of herba lobeliae chinensis, 10 to 12 parts of duchesnea indica, 12 to 15 parts of radix actinidiae chinensis, 10 to 12 parts of herba rabdosiae and 7 to 9 parts of red yeast rice. According to the traditional Chinese medicine composition provided by the invention, medicine compatibility is carried out according to the treatment rule of dissolving turbidity and detoxifying, a good curative effect on precancerous lesions of the gastric cancer is achieved clinically, the viewpoint that the precancerous lesions of the gastric cancer are difficult to reverse can be reversed, and the medicine prevention of the early gastric cancer becomes possible.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating gastric precancerous lesions, and a preparation method and application thereof. Background Art

[0002] Gastric cancer is the second leading cause of cancer death in the world, second only to lung cancer. Gastric precancerous lesions have a canceration rate of about 10%, and in areas with a high incidence of gastric cancer, it can reach 28%, highlighting the importance of preventing and treating gastric precancerous lesions. At present, Western medicine treatment of gastric precancerous lesions mainly includes endoscopic treatment and drug treatment. However, there are disadvantages such as complications and drug resistance. There is no disease name corresponding to gastric precancerous lesions in ancient Chinese medical books, but according to its clinical symptoms, it is mostly classified into the categories of "fullness", "epigastric pain", "noisy" and so on. Therefore, even if the existing technology uses a Chinese medicine composition to treat gastric cancer, it usually combines drugs from the direction of improving "fullness", "epigastric pain", "noisy" and so on, and cannot achieve the treatment of gastric precancerous lesions. Summary of the invention

[0003] In view of this, the object of the present invention is to provide a Chinese medicine composition, which takes clearing turbidity and detoxifying as the drug compatibility principle, and treats gastric precancerous lesions by eliminating dampness and turbidity from the inside and enhancing the effects of reducing swelling, clearing heat and detoxifying.

[0004] The present invention provides a traditional Chinese medicine composition, comprising the following traditional Chinese medicine raw materials in parts by weight:

[0005] 10-15 parts of Patchouli, 9-12 parts of Perilla frutescens, 12-15 parts of Artemisia capillaris, 10-12 parts of Coptis chinensis, 10-12 parts of Citrus aurantium, 9-12 parts of Atractylodes macrocephala, 12-20 parts of Oldenlandia diffusa, 12-20 parts of Lobelia, 10-12 parts of Duchesnea indica, 12-15 parts of Rhizoma Cibotii, 10-12 parts of Rubescens rubescens and 7-9 parts of Red yeast rice.

[0006] Preferably, the composition comprises the following Chinese medicinal raw materials in parts by weight: 11-14 parts of Patchouli, 9-11 parts of Cyperus rotundus, 11-14 parts of Capillaris, 11-12 parts of Coptis chinensis, 11-12 parts of Immature Citrus aurantium, 9-11 parts of Atractylodes macrocephala, 12-18 parts of Oldenlandia diffusa, 12-18 parts of Lobelia, 11-12 parts of Duchesnea indica, 12-14 parts of Rhizoma Cibotii, 11-12 parts of Rubescens rubescens and 8-9 parts of Monascus.

[0007] Preferably, the composition comprises the following Chinese medicinal raw materials in parts by weight: 12 parts of Patchouli, 9 parts of Perilla frutescens, 12 parts of Artemisia capillaris, 12 parts of Coptis chinensis, 12 parts of Immature Citrus aurantium, 9 parts of Atractylodes macrocephala, 12 parts of Oldenlandia diffusa, 12 parts of Lobelia, 12 parts of Duchesnea indica, 12 parts of Rhizoma Cibotii, 12 parts of Rhizoma Rubescens ... and 9 parts of Red Yeast.

[0008] The present invention provides a method for preparing the Chinese medicine composition, comprising the following steps:

[0009] The Chinese medicinal raw materials of the Chinese medicinal composition are soaked in water, refluxed for extraction, and the medicinal liquid is collected.

[0010] Preferably, the mass ratio of the Chinese medicinal raw materials to water is 1:(8-12).

[0011] Preferably, the soaking time is 50 to 70 minutes;

[0012] The reflux extraction time is 100 to 140 minutes.

[0013] Preferably, the medicinal residue obtained after the reflux extraction further comprises reflux extraction again;

[0014] During the second reflux extraction, the mass ratio of the medicinal residue to water is 1:6-10; and the time for the second reflux extraction is 80-100 minutes.

[0015] Preferably, before the soaking, the Chinese medicinal raw materials are crushed; the particle size of the crushed Chinese medicinal raw materials is 4 to 6 mm.

[0016] The present invention provides the use of the Chinese medicine composition or the Chinese medicine composition obtained by the preparation method in preparing a medicine for preventing and / or treating gastric precancerous lesions and / or preventing early gastric cancer.

[0017] Preferably, the gastric precancerous lesions include at least one of the following symptoms: gastric mucosal congestion and edema, gastric mucosal erosion, red and white gastric mucosa, naked blood vessels, bile reflux and granular hyperplasia.

[0018] The present invention provides a Chinese medicine composition, comprising the following Chinese medicine raw materials by weight: 10-15 parts of Patchouli, 9-12 parts of Perilla, 12-15 parts of Artemisia capillaris, 10-12 parts of Coptis chinensis, 10-12 parts of Citrus aurantium, 9-12 parts of Atractylodes macrocephala, 12-20 parts of Hedyotis diffusa, 12-20 parts of Lobelia, 10-12 parts of Duchesnea, 12-15 parts of Rhizoma Cibotii, 10-12 parts of Rabdosia rubescens and 7-9 parts of Red Yeast. After years of clinical practice and basic research, it was found that gastric precancerous lesions are mostly caused by dietary internal injuries and emotional frustration, leading to liver-stomach disharmony, dysfunction of descent, failure of clear yang to rise, and turbid evil stagnation. Over time, the spleen loses its healthy function, water and dampness cannot be transformed, dampness and turbidity are blocked in the middle, depression and unresolved, accumulation into heat, heat congestion and blood stasis into toxicity, and formation of turbid toxins. Turbid toxins are the result of causing organ dysfunction, abnormal qi and blood circulation, and the inability of metabolic products in the body to be discharged in time and accumulated in the body. It can be seen that turbid toxins are the main cause and pathogenesis throughout the process of gastric precancerous lesions, and are also pathogenic factors that cause serious damage to the human body. The present invention uses the method of removing turbidity and detoxification to treat gastric precancerous lesions with drug compatibility, wherein the aromatic products of Patchouli and Perilla are used to soothe the spleen and wake up the spleen, eliminate dampness and turbidity inside, and the combination of Hedyotis diffusa, Lobelia, Duchesnea, Rhizoma Coptidis, and Rubus rubescens strengthens the function of detumescence, heat-clearing and detoxification, Artemisia capillaris and Coptis chinensis clear away heat and dampness, Citrus aurantium removes qi and eliminates lumps, Atractylodes macrocephala strengthens the spleen and replenishes qi, and Red yeast rice strengthens the spleen and activates blood circulation, and has achieved good clinical effects. It is to prevent and treat gastric precancerous lesions, to reverse gastric precancerous lesions and reduce the incidence of early gastric cancer. Experiments show that with the Western medicine treatment scheme as the control group, the decoction prepared by the present invention using the Chinese medicine composition can reduce the clinical symptom score, has excellent therapeutic efficiency, and the total effective rate is above 93%. At the same time, the results of gastroscopy showed that the Chinese medicine composition treatment group can effectively improve symptoms such as gastric mucosal congestion and edema, gastric mucosal erosion, gastric mucosal red and white, naked blood vessels, bile reflux and granular hyperplasia. In addition, the Chinese medicine composition can also improve pathological symptoms such as gastric mucosal atrophy, intestinal metaplasia and atypical hyperplasia, and can reduce the levels of serum tumor markers CEA and CA19-9, and the treatment effect is better than that of the control group. It can be seen that the Chinese medicine composition provided by the present invention is compatible with drugs based on the "Huazhuo Jiedu Fang" treatment principle, and the treatment of gastric precancerous lesions has achieved good clinical results, which can reverse the view that gastric precancerous lesions are difficult to reverse, and make drug prevention of early gastric cancer possible. DETAILED DESCRIPTION

[0019] The invention provides a traditional Chinese medicine composition, comprising the following traditional Chinese medicine raw materials in parts by weight: 10-15 parts of Patchouli, 9-12 parts of Perilla frutescens, 12-15 parts of Artemisia capillaris, 10-12 parts of Coptis chinensis, 10-12 parts of Citrus aurantium, 9-12 parts of Atractylodes macrocephala, 12-20 parts of Hedyotis diffusa, 12-20 parts of Lobelia, 10-12 parts of Duchesnea indica, 12-15 parts of Rhizoma Cibotii, 10-12 parts of Rubescens rubescens and 7-9 parts of Red yeast rice.

[0020] In the present invention, the Chinese medicine composition preferably includes the following Chinese medicine raw materials in parts by weight: 11-14 parts of Patchouli, 9-11 parts of Perilla frutescens, 11-14 parts of Artemisia capillaris, 11-12 parts of Coptis chinensis, 11-12 parts of Citrus aurantium, 9-11 parts of Atractylodes macrocephala, 12-18 parts of Hedyotis diffusa, 12-18 parts of Lobelia chinensis, 11-12 parts of Duchesnea indica, 12-14 parts of Rhizoma Cibotii, 11-12 parts of Rubescens rubescens, and 8-9 parts of Red Yeast Rice. More preferably, the Chinese medicine composition includes the following Chinese medicine raw materials in parts by weight: 11-13 parts of Patchouli, 9-10 parts of Perilla frutescens, 11-13 parts of Artemisia capillaris, Coptis chinensis, The invention relates to a preparation method comprising the following raw materials in parts by weight: 11.5-12 parts of Herba Citrus Aurantii Immaturus, 11.5-12 parts of Herba Atractylodes Macrocephalae, 9-10 parts of Herba Hedyotis Diffusae, 12-15 parts of Herba Lobeliae, 11.5-12 parts of Herba Duchesneae, 12-13 parts of Herba Cynoglossi, 11.5-12 parts of Herba Rubescens and 8.5-9 parts of Red Yeast Rice. The most preferred raw materials include the following parts by weight: 12 parts of Herba Patchouli, 9 parts of Herba Cynoglossi, 12 parts of Herba Capillaris, 12 parts of Herba Coptis Chinensis, 12 parts of Herba Citrus Aurantii Immaturus, 9 parts of Herba Atractylodes Macrocephalae, 12 parts of Herba Hedyotis Diffusae, 12 parts of Herba Lobeliae, 12 parts of Herba Duchesneae, 12 parts of Herba Cynoglossi, 12 parts of Herba Cynoglossi, 12 parts of Herba Rubescens and 9 parts of Red Yeast Rice.

[0021] In the present invention, the effects of Patchouli are to dispel wind and cold, dispel dampness, induce sweating, and resist bacteria. In clinical practice, the effect of Patchouli is mainly reflected in the digestive tract, and Patchouli can be used to form medicines to treat spasms of the digestive tract, such as gastritis, gastroenteritis, and spasms of the gastrointestinal tract, as well as related symptoms such as diarrhea, stomachache, and vomiting. The Perilla frutescens has the effects of removing dampness and relieving heat, and is clinically effective in treating symptoms such as dampness and heat, anxiety, etc. The Artemisia capillaris has the effects of clearing dampness and heat, jaundice, and gallbladder protection and liver protection, and is commonly used for antipyretic analgesia, treatment of colds, and also has the effect of protecting the liver and gallbladder. The Coptis chinensis has the effects of clearing heat and drying dampness, purging fire and detoxifying, can effectively inhibit bacteria, protect the gastric mucosa, and has anti-inflammatory and analgesic effects. The Fructus Aurantii Immaturus is a Qi-moving medicine, which has the effects of breaking qi and eliminating accumulation, resolving phlegm and dispersing lumps, and is mainly used to treat chest and abdominal distension, chest pain, lumps, edema, food accumulation, constipation, gastroptosis, etc. The Atractylodes macrocephala has the effects of invigorating the spleen and replenishing qi, drying dampness and promoting diuresis, stopping sweat and stabilizing pregnancy, and is mainly attributed to the spleen meridian and stomach meridian, with invigorating the spleen and drying dampness as the main function. The white flower oldenlandia has the effects of clearing away heat and detoxicating, promoting dampness and relieving stranguria, and is clinically used for sore throat, snake bites or carbuncle swelling and ulcer. The lobelia has the effects of clearing heat and detoxicating, promoting diuresis and reducing swelling, and is clinically used to treat carbuncle swelling and ulcer, breast carbuncle swelling and pain, snake bites, abdominal distension and edema, jaundice and oliguria, eczema and eczema. The snakeberry has certain effects of clearing heat and cooling blood, reducing swelling and detoxicating, promoting diuresis and penetrating dampness, and can effectively improve the effects of oral sores and dry stool. The root of rattan pear has the effects and functions of clearing heat and detoxicating, promoting blood circulation and relieving pain, and is used for tumor treatment. By clearing heat and detoxicating, it can inhibit the growth of cancer cells and soften and disperse nodules. The root of rattan pear also has the effects of dredging meridians and relieving pain. The winter grass has the effects of clearing away heat and detoxicating, promoting blood circulation and relieving pain, and is used for sore throat, lumps and masses, and snake and insect bites. The red yeast rice has the effects of promoting blood circulation and removing blood stasis, strengthening the spleen and digesting food, and is mainly used for food stagnation, abdominal distension, red and white diarrhea, postpartum lochia, traumatic injuries, etc. The principle of the monarch, minister, assistant and envoy compatibility of the Chinese medicine composition provided by the present invention is as follows: with Patchouli and Perilla as the monarch medicine, the spleen and dampness are strengthened, with Artemisia capillaris, Coptis chinensis, Citrus aurantium, and Atractylodes macrocephala as the minister medicine, the heat-clearing and dampness-removing, spleen-strengthening effects are played, with Hedyotis diffusa, Semi-spined Coptis chinensis, Duchesnea, Winter Grass, and Red Yeast as adjuvants, the heat-clearing and detoxicating, blood-activating effects are played. The present invention has no special restrictions on the source of the Chinese medicine raw materials, and the sources of the above-mentioned Chinese medicine raw materials known in the art can be used. In the embodiment of the present invention, the Chinese medicine raw materials are all purchased from the Chinese medicine pharmacy of Tangshan People's Hospital.

[0022] The present invention provides a method for preparing the Chinese medicine composition, comprising the following steps:

[0023] The Chinese medicinal raw materials of the Chinese medicinal composition are soaked in water, refluxed for extraction, and the medicinal liquid is collected.

[0024] In the present invention, before the soaking, it is preferred that the Chinese medicine raw material is crushed so as to fully extract the active pharmaceutical ingredients in the Chinese medicine raw material. The particle size of the crushed Chinese medicine raw material is preferably 4-6 mm, more preferably 5 mm. During the soaking, the mass ratio of the Chinese medicine raw material to water is preferably 1:8-12, more preferably 1:10. The soaking time is preferably 50-70 min, more preferably 60 min. The soaking is conducive to the subsequent full extraction of the active pharmaceutical ingredients in the Chinese medicine raw material. The reflux extraction time is preferably 100-140 min, more preferably 120 min. The present invention has no special restrictions on the temperature of the reflux extraction, and the conventional temperature for reflux extraction with water as a solvent can be used. In order to further fully extract the active pharmaceutical ingredients in the Chinese medicine raw material, the dregs obtained after the reflux extraction preferably also include re-reflux extraction. During the re-reflux extraction, the mass ratio of the dregs to water is preferably 1: (6-10), more preferably 1: 8. The re-reflux extraction time is preferably 80-100 min, more preferably 90 min.

[0025] The present invention provides the use of the Chinese medicine composition or the Chinese medicine composition obtained by the preparation method in preparing a medicine for preventing and / or treating gastric precancerous lesions and / or preventing early gastric cancer.

[0026] In the present invention, the gastric precancerous lesions preferably include at least one of the following symptoms: gastric mucosal congestion and edema, gastric mucosal erosion, gastric mucosal red and white, naked blood vessels, bile reflux and granular hyperplasia. The Chinese medicine composition can effectively improve the symptoms of gastric mucosal congestion and edema, gastric mucosal erosion, gastric mucosal red and white, naked blood vessels, bile reflux and granular hyperplasia, improve gastric pathological symptoms, and at the same time can reduce clinical symptom scores, reduce gastric cancer tumor marker levels, and improve clinical treatment effects.

[0027] In the present invention, the medicine preferably includes decoctions, pills, etc. The medicine is preferably an oral agent. The dosage of the medicine is preferably 1 dose / day. One dose of Chinese medicinal raw materials includes the following content components: Patchouli 10-15g, Perilla 9-12g, Artemisia capillaris 12-15g, Coptis chinensis 10-12g, Citrus aurantium 10-12g, Atractylodes macrocephala 9-12 parts, Hedyotis diffusa 12-20g, Lobelia 12-20g, Duchesnea 10-12g, Rhizoma Cibotii 12-15g, Rubescens 10-12g and Monascus 7-9g. The volume of the decoction of one dose of Chinese medicinal composition is 500ml, which is taken in 2 times, 3 months as a course of treatment, and 2 courses of treatment are observed.

[0028] The following is a detailed description of a Chinese medicine composition for treating gastric precancerous lesions provided by the present invention, as well as its preparation method and application, in conjunction with the embodiments. However, they should not be construed as limiting the scope of protection of the present invention.

[0029] Example 1

[0030] A Chinese medicine composition for treating gastric precancerous lesions and its preparation method

[0031] 1) Weigh the following medicinal materials by weight: Patchouli 10g, Perilla frutescens 9g, Artemisia capillaris 12g, Coptis chinensis 10g, Citrus aurantium 10g, Atractylodes macrocephala 9g, Hedyotis diffusa 12g, Lobelia 12g, Duchesnea indica 10g, Pyrus nobilis 12g, Rubescens rubescens 10g, and Monascus 7g. The above dosage is for one dose.

[0032] 2) Preparation method:

[0033] The above medicinal materials were mixed and crushed into a diameter of mung bean size (4-5 mm), soaked in 10 times the mass of water for 1 hour, and refluxed for 2 hours. The filtrate was filtered and recovered, and the obtained filter residue was added with 8 times the mass of water, and refluxed for 1.5 hours again, and the two filtrates were combined to obtain a Chinese medicine composition decoction.

[0034] Example 2

[0035] A Chinese medicine composition for treating gastric precancerous lesions and its preparation method

[0036] 1) Weigh the following medicinal materials by weight: Patchouli 12g, Perilla frutescens 10g, Artemisia capillaris 12g, Coptis chinensis 10g, Citrus aurantium 12g, Atractylodes macrocephala 10g, Hedyotis diffusa 15g, Lobelia 15g, Duchesnea indica 12g, Pyrus truncatula 12g, Rubescens rubescens 12g, and Monascus 9g. The above dosage is for one dose.

[0037] 2) The above medicinal materials were mixed and crushed into mung bean-sized pieces (4-5 mm), and a Chinese medicine composition decoction was prepared according to the method of Example 1.

[0038] Example 3

[0039] A Chinese medicine composition for treating gastric precancerous lesions and its preparation method

[0040] 1) Weigh the following medicinal materials by weight: 15g of Patchouli, 12g of Perilla frutescens, 15g of Artemisia capillaris, 12g of Coptis chinensis, 10g of Citrus aurantium, 12g of Atractylodes macrocephala, 20g of Hedyotis diffusa, 15g of Lobelia chinensis, 12g of Duchesnea indica, 15g of Rhizoma Cibotii, 12g of Rabdosia rubescens, and 9g of Monascus. The above dosage is for one dose.

[0041] 2) Preparation method:

[0042] The above medicinal materials were mixed and crushed into mung bean size (4-5 mm), and a Chinese medicine composition decoction was prepared according to the method of Example 1.

[0043] Example 4

[0044] Clinical efficacy evaluation of Chinese herbal medicine decoctions

[0045] 1. Research methods:

[0046] Screening of patients with gastric cancer precancerous lesions: Please provide screening criteria for patients with gastric cancer precancerous lesions.

[0047] Referring to the "Expert Consensus on Treatment Strategies for Gastric Mucosal Precancerous Conditions and Precancerous Lesions in China (2020)" formulated by the National Clinical Research Center for Digestive Diseases (Shanghai), gastric precancerous conditions are defined as gastric mucosal atrophy (CAG) and intestinal metaplasia (IM), and gastric precancerous lesions are defined as gastric intraepithelial neoplasia (GIN). Low-grade intraepithelial neoplasia of the gastric mucosa is equivalent to mild and moderate gastric mucosal dysplasia, and high-grade intraepithelial neoplasia is equivalent to high-grade dysplasia. The diagnosis of gastric mucosal atrophy and intestinal metaplasia refers to the "Chinese Consensus on Chronic Gastritis (2017, Shanghai)" formulated by the Gastroenterology Branch of the Chinese Medical Association.

[0048] 80 patients with gastric precancerous lesions who met the diagnostic criteria and exclusion criteria were randomly divided into groups, 40 cases in the control group and 40 cases in the treatment group. The control group was given Western medicine treatment, specifically, the patients in the control group were given 0.8g of Weimeisu tablets (Tianzifu International Pharmaceutical Jiangsu Co., Ltd., National Medicine Standard H32025818, Specification: 0.2g) orally, 3 times / d, for a course of 3 months. The treatment group was given the Chinese medicine composition decoction prepared in Examples 1 to 3, and the method of taking was 1 dose / day, divided into 2 doses, 3 months as a course of treatment, and 2 courses of treatment were observed.

[0049] 2. Observation indicators

[0050] 1) Clinical symptom scores and TCM syndrome scores of the two groups before and after treatment;

[0051] The clinical efficacy is divided into cure, marked effect, effectiveness, and ineffectiveness. The specific symptom grading and quantitative evaluation refers to the TCM syndrome questionnaire (Table 1) developed by the expert group after discussion in the "Symptom Part of TCM Diagnosis and Treatment Terminology". The severity of the symptoms is quantified into four levels: none, mild, moderate, and severe, which are recorded as 0, 1, 2, and 3 points respectively. See Table 2 for details.

[0052] Table 1 TCM syndrome questionnaire for gastric precancerous lesions

[0053]

[0054]

[0055] Table 2 Main TCM syndrome scoring table

[0056]

[0057] The evaluation of syndrome efficacy was carried out according to the standards stipulated in the Guiding Principles for Clinical Research of New Chinese Medicines.

[0058] Clinical recovery: TCM clinical symptoms and signs disappear or basically disappear, and syndrome score>95%;

[0059] Markedly effective: clinical symptoms and signs of TCM are significantly improved, with syndrome score ≥ 70%;

[0060] Effective: TCM clinical symptoms and signs have improved, and the syndrome score is ≥30%;

[0061] Ineffective: TCM clinical symptoms and signs have no significant improvement or even worsen, and the syndrome score is <30%;

[0062] Therapeutic index (n) = (score before treatment - score after treatment) / score before treatment × 100%.

[0063] The calculation formula of total effective rate is shown in Formula I:

[0064] Total effective rate (%) = (clinical cure + marked effect + effective) / (clinical cure + marked effect + effective + ineffective) × 100% Formula I

[0065] TCM symptom score: before and after treatment, according to the "Guidelines for Clinical Research of New Chinese Medicines (Trial)", epigastric distension, stomach pain, belching and acid reflux, nausea and vomiting, and localized pain were selected as the main symptoms, and each symptom was scored from mild to severe according to the severity. The therapeutic efficacy of TCM on the syndrome was determined by statistical methods.

[0066] 2) Gastroscopy was used to observe gastric mucosal symptoms and pathological findings in the two groups before and after treatment;

[0067] 3) The changes in carcinoembryonic antigen levels (CEA and CA19-9) in the two groups before and after treatment were examined by chemiluminescence method using commercial detection kits (purchased from Roche, catalog numbers 749425 and 759014).

[0068] 3. Statistical methods

[0069] SPSS 22.0 statistical software was used to analyze the data. The chi-square test and t-test were used to compare the count data and normal distribution data between groups, respectively, and the measurement data were expressed as mean ± standard deviation.

[0070] 4. Test results

[0071] 1) Comparison of clinical symptom scores, the results are shown in Table 3. Both the treatment group and the control group were able to reduce the clinical symptom scores, and when the clinical symptom scores of the treatment group were similar to those of the control group before treatment, the clinical symptom scores of the treatment group were significantly reduced after treatment.

[0072] Table 3 Comparison of clinical syndrome scores between the two groups of patients

[0073] Group Number of cases Before treatment After treatment Treatment Group 30 17.29±3.65 6.31±2.02*△ Control group 30 17.78±4.69 11.31±3.98*

[0074] Note: Compared with before treatment, *P<0.05; compared with the control group, △P<0.05.

[0075] 2) The results of clinical efficacy comparison are shown in Table 4. Compared with the control group, the total effective rate of the treatment was significantly higher than that of the control group, reaching 93.33%.

[0076] Table 4 Comparison of clinical efficacy between the two groups of patients

[0077] Group Number of cases cure Significant effect efficient invalid Total effective rate (%) Treatment Group 30 17 8 3 2 93.33%△ Control group 30 6 9 8 7 76.67%

[0078] Note: Compared with the control group, △P<0.05.

[0079] 3) Comparison of gastroscopy, the results are shown in Table 5. According to statistics, compared with the control group, the improvement rates of gastric mucosal congestion and edema, erosion, red and white, blood vessel exposure, bile reflux and granular hyperplasia in the treatment group were significantly better than those in the control group.

[0080] Table 5 Comparison of gastroscopy between the two groups of patients

[0081]

[0082]

[0083] Note: Compared with before treatment, *P<0.05; compared with the control group, △P<0.05.

[0084] 4) Comparison of pathological results (see Table 6).

[0085] Table 6 Comparison of pathological results between the two groups of patients

[0086]

[0087] Note: Compared with the control group, △P<0.05.

[0088] 5) Comparison of serum tumor marker levels, the results are shown in Table 7. After treatment, the levels of tumor markers in both the treatment group and the control group were significantly reduced, and compared with the control group, the treatment group had a significant difference in reducing the levels of tumor markers.

[0089] Table 7 Comparison of serum tumor marker levels between the two groups of patients (x±s)

[0090]

[0091] Note: Compared with before treatment, *P<0.05; compared with the control group, △P<0.05.

[0092] In summary, the Chinese medicine composition decoction provided by the present invention has obvious advantages over Western medicine treatment in improving gastric mucosal lesions and pathological conditions, clinical treatment efficacy, and reducing serum tumor marker levels. Therefore, the Chinese medicine composition has a high application value in treating gastric precancerous lesions and preventing early gastric cancer.

[0093] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicine composition, characterized in that: Including the following Chinese medicine raw materials by weight: 10-15 parts of Patchouli, 9-12 parts of Perilla frutescens, 12-15 parts of Artemisia capillaris, 10-12 parts of Coptis chinensis, 10-12 parts of Citrus aurantium, 9-12 parts of Atractylodes macrocephala, 12-20 parts of Oldenlandia diffusa, 12-20 parts of Lobelia, 10-12 parts of Duchesnea indica, 12-15 parts of Rhizoma Cibotii, 10-12 parts of Rubescens rubescens and 7-9 parts of Red yeast rice.

2. The Chinese medicine composition according to claim 1, characterized in that: The invention comprises the following Chinese medicinal raw materials in parts by weight: 11-14 parts of Patchouli, 9-11 parts of Cymbidium, 11-14 parts of Artemisia Capillaris, 11-12 parts of Coptis chinensis, 11-12 parts of Citrus aurantium, 9-11 parts of Atractylodes macrocephala, 12-18 parts of Oldenlandia diffusa, 12-18 parts of Lobelia, 11-12 parts of Duchesnea indica, 12-14 parts of Rhizoma Cyperi, 11-12 parts of Rubescens rubescens and 8-9 parts of Red yeast rice.

3. The Chinese medicine composition according to claim 1 or 2, characterized in that: The invention comprises the following Chinese medicinal raw materials in parts by weight: 12 parts of Patchouli, 9 parts of Perilla frutescens, 12 parts of Artemisia capillaris, 12 parts of Coptis chinensis, 12 parts of Citrus aurantium, 9 parts of Atractylodes macrocephala, 12 parts of Oldenlandia diffusa, 12 parts of Lobelia, 12 parts of Duchesnea indica, 12 parts of Rhizoma Cibotii, 12 parts of Rhizoma Rubescens ... and 9 parts of Red yeast rice.

4. The method for preparing the Chinese medicine composition according to any one of claims 1 to 3, characterized in that: The following steps are involved: The Chinese medicinal raw materials of the Chinese medicinal composition are soaked in water, refluxed for extraction, and the medicinal liquid is collected.

5. The preparation method according to claim 4, characterized in that: The mass ratio of the Chinese medicinal raw materials to water is 1:8-12.

6. The preparation method according to claim 4, characterized in that: The soaking time is 50 to 70 minutes; The reflux extraction time is 100 to 140 minutes.

7. The preparation method according to claim 4, characterized in that: The medicinal residue obtained after the reflux extraction further comprises reflux extraction again; During the second reflux extraction, the mass ratio of the medicinal residue to water is 1:(6-10); and the time for the second reflux extraction is 80-100 minutes.

8. The preparation method according to any one of claims 4 to 7, characterized in that: Before the soaking, the Chinese medicinal raw materials are crushed; the particle size of the crushed Chinese medicinal raw materials is 4 to 6 mm.

9. Use of the Chinese medicine composition according to any one of claims 1 to 3 or the Chinese medicine composition obtained by the preparation method according to any one of claims 4 to 8 in the preparation of a drug for treating gastric precancerous lesions and / or preventing early gastric cancer.

10. The use according to claim 9, characterized in that: The gastric precancerous lesions include at least one of the following symptoms: gastric mucosal congestion and edema, gastric mucosal erosion, red and white gastric mucosa, naked blood vessels, bile reflux and granular hyperplasia.

Citation Information

Patent Citations

  • Traditional Chinese medicine for treating atrophic gastritis with intestinal metaplasia and atypical hyperplasia

    CN103230519A

  • Traditional Chinese medicine preparation for treating chronic gastritis

    CN104645202A

  • Traditional Chinese medicine prescription for treating turbid toxin syndrome of chronic atrophic gastritis

    CN111184825A